Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
Diagnostic confirmation of Fabry disease when familial mutations have
been previously identified
Carrier screening of at-risk individuals when a mutation in the GLA gene
has been identified in an affected family member
| Unit Code | Reporting Name | Available Separately | Always Performed |
| 80333 | Fibroblast Culture for Genetic Test | Yes | No |
| 80334 | Amniotic Fluid Culture/Genetic Test | Yes | No |
If amniotic fluid (non-confluent cultured cells) is received, amniotic
fluid culture/genetic test will be added and charged separately. If
chorionic villus specimen (non-confluent cultured cells) is received,
fibroblast culture for genetic test will be added and charged separately.
88266: Polymerase Chain Reaction (PCR) Amplification/DNA
Sequencing is utilized to test for the presence of a
specific mutation in the GLA gene previously identified
in an affected family member.
(PCR is utilized pursuant to a license agreement with
Roche Molecular Systems, Inc.)
80333, 80334: Cell Culture
Fabry Disease Known Mutation
FABRYKM
FABKM
alpha-galactosidase A
cardiac variant Fabry disease
renal variant Fabry disease

